# Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

> **NCT06755541** · PHASE3 · RECRUITING · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 150 (estimated)

## Conditions studied

- Primary Biliary Cholangitis (PBC)

## Interventions

- **DRUG:** Fenofibrate in Combination With Ursodeoxycholic Acid

## Key facts

- **NCT ID:** NCT06755541
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-30
- **Primary completion:** 2035-12
- **Final completion:** 2035-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06755541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06755541, "Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06755541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*